<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kumar S</submitter><funding>NCRR NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>4036-51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3187352</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(19)</volume><pubmed_abstract>Detachment of epithelial cells from matrix or attachment to an inappropriate matrix engages an apoptotic response known as anoikis, which prevents metastasis. Cellular sensitivity to anoikis is compromised during the oncogenic epithelial-to-mesenchymal transition (EMT), through unknown mechanisms. We report here a pathway through which EMT confers anoikis resistance. NRAGE (neurotrophin receptor-interacting melanoma antigen) interacted with a component of the E-cadherin complex, ankyrin-G, maintaining NRAGE in the cytoplasm. Oncogenic EMT downregulated ankyrin-G, enhancing the nuclear localization of NRAGE. The oncogenic transcriptional repressor protein TBX2 interacted with NRAGE, repressing the tumor suppressor gene p14ARF. P14ARF sensitized cells to anoikis; conversely, the TBX2/NRAGE complex protected cells against anoikis by downregulating this gene. This represents a novel pathway for the regulation of anoikis by EMT and E-cadherin.</pubmed_abstract><journal>Molecular and cellular biology</journal><pubmed_title>A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.</pubmed_title><pmcid>PMC3187352</pmcid><funding_grant_id>RR020866</funding_grant_id><funding_grant_id>P20 RR016440</funding_grant_id><funding_grant_id>S10 RR020866</funding_grant_id><funding_grant_id>P30 GM103488</funding_grant_id><funding_grant_id>P20 RR16440</funding_grant_id><funding_grant_id>R01 CA123359</funding_grant_id><funding_grant_id>R01CA123359</funding_grant_id><pubmed_authors>Schupp J</pubmed_authors><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Cieply B</pubmed_authors><pubmed_authors>Killiam E</pubmed_authors><pubmed_authors>Frisch SM</pubmed_authors><pubmed_authors>Park SH</pubmed_authors><pubmed_authors>Rimm DL</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.</name><description>Detachment of epithelial cells from matrix or attachment to an inappropriate matrix engages an apoptotic response known as anoikis, which prevents metastasis. Cellular sensitivity to anoikis is compromised during the oncogenic epithelial-to-mesenchymal transition (EMT), through unknown mechanisms. We report here a pathway through which EMT confers anoikis resistance. NRAGE (neurotrophin receptor-interacting melanoma antigen) interacted with a component of the E-cadherin complex, ankyrin-G, maintaining NRAGE in the cytoplasm. Oncogenic EMT downregulated ankyrin-G, enhancing the nuclear localization of NRAGE. The oncogenic transcriptional repressor protein TBX2 interacted with NRAGE, repressing the tumor suppressor gene p14ARF. P14ARF sensitized cells to anoikis; conversely, the TBX2/NRAGE complex protected cells against anoikis by downregulating this gene. This represents a novel pathway for the regulation of anoikis by EMT and E-cadherin.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Oct</publication><modification>2024-10-18T03:59:45.453Z</modification><creation>2019-03-27T00:44:37Z</creation></dates><accession>S-EPMC3187352</accession><cross_references><pubmed>21746881</pubmed><doi>10.1128/MCB.01342-10</doi><doi>10.1128/mcb.01342-10</doi></cross_references></HashMap>